CClinicalTrials.gg
Status unknownNCT03786458Updated May 9, 2022

Development and Evaluation of Web-Based Fertility-Related Decision Support for Young Female Cancer Patients

An interventional study of web-based decision aid in Infertility, Female and Female Infertility, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Open to female participants aged 20 Years to 44 Years. Per ClinicalTrials.gov, last updated 2022-05-09.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
115
Allocation
Not applicable
Ages
20 Years to 44 Years
Sex
Female
01

Study summary

This study aims to develop a patient-centered, user-center, interactive web-based decision aid to support the young women with cancer in making an informed fertility-related decision and further evaluate its efficacy.

Read the detailed description

This study uses mixed-method and involves 2 stages. As following the IPDAS recommendation for developing decision aids, the first sample of 25 young woman survivors with breast, hematology or ovarian cancer, and oncologist, fertility specialists or nurses will be interviewed to assess the fertility-related decision needs from and. The decision aid is then developed further process of evidence synthesis and multidisciplinary external review. After the draft being evaluated for its validity via Think-aloud cognitive interview method, field testing via one-group quasi-experimental design on 90 young women with newly diagnosed breast, hematology or ovarian cancer will be applied to test its outcomes of decision quality, emotional health and fertility concerns.

02

Conditions studied

  • Infertility, Female
  • Female Infertility

Keywords

  • Infertility
  • young female cancer patients
  • decision aids
  • fertility concerns
03

In context

Infertility

2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.

This study's planned enrollment of 115 is close to the median of 120 across 1,698 interventional studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 44 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Age between 20 to 44
  • Have been diagnosed with breast, hematology or ovarian cancer, and will conduct cancer treatment, such as chemotherapy, hormonal or radiation.
  • Willing to take questionnaire via computer and tablet.
  • Ability to answer the questionnaire with functional emotion and cognition.
  • Ability to read newspaper.
  • Had been consulted and advised by Doctor on the ability of fertility, but have not decided to give birth to a baby.

Exclusion criteria

Exclusion Criteria:

  • Age below 20 or above 45.
  • Had been diagnosed with stage 4 cancer.
  • Do not require chemotherapy, hormonal or radiation therapy.
  • Not able to read newspaper or do not access the internet.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
115 participants (estimated)

Study arms

  • Experimental
    Cancer and Fertility Decision making

    Cancer and Fertility Decision aid

    Behavioral: web-based decision aid

Interventions

  • Behavioralweb-based decision aid

    The decision aid is then developed further process of evidence synthesis and multidisciplinary external review.

06

What researchers measure

Primary outcomes

  1. Decision conflict,decision regret,fertility knowledge,reproductive concerns after cancer,quality of life

    Decisional scale

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • National Taiwan University Hospital
    Taipei City, Taipei 10048, Taiwan
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 9, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03786458
Lead sponsor
National Taiwan University Hospital
Responsible party
Sponsor
First posted
Dec 26, 2018
Start date
Jan 11, 2019
Primary completion
Aug 31, 2022 (estimated)
Completion
Nov 27, 2022 (estimated)
Last update
May 9, 2022

Study contacts

Shiu-Yu K Lee, PhD
Contact
shiuyu@ntunhs.edu.tw
886-2-2822-7101 ext. 3316
Wen-Fang Cheng
principal investigator · National Taiwan University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion